Miao and colleagues (2020) have recently suggested that NOTCH1 activation can regulate the cell cycle and attenuate BRCA1 deficiency-induced G2/M blockade and genomic instability, thus providing tumor cells with a survival advantage [31]. Here, NOTCH1 is linked to neoplasm.